Good News: Teen Pregnancies Hit New Low In the US

By MIKE MAGEE Last week, policy wonks from the right and the left, finally found a topic they could agree on – Kids are no longer having (as many) kids. Specifically, teen pregnancies dropped an additional 10% in the US in 2025. This is an acceleration of a trend which began two decades ago. Teen births…

Read More

Abridge Goes Beyond Documentation: 4 Updates

Clinical AI startup Abridge held a New York City event to signal it’s done being thought of as just an AI scribe. The company announced a Nvidia foundation model partnership, an Eli Lilly investment, new capabilities for its platform, and the intent to help mediate the relationship between payers and providers. The post Abridge Goes…

Read More

Oceans, Away

By KIM BELLARD It probably didn’t show up on your calendar, but Monday was World Ocean Day. It’s a day meant to catalyze “collective action for a healthy ocean and a stable climate,” and has been around since 2002 (although the U.N. didn’t officially recognize it until 2008). Its website claims a network of over…

Read More

A Simple Act of Kindness Creates a Lasting Impact at Texas Children’s Hospital

Sometimes the most meaningful moments of care happen when someone simply takes the time to be present.  While making her regular rounds at Texas Children’s Hospital, The Woodlands, Environmental Services (EVS) Houskeeper Maruja Caballero, heard a young patient crying. When she arrived at his room to collect the trash, she stopped in her tracks and moved into action to help.  …

Read More

Novartis RNA Med From $12B Deal Keeps Building Case to Become First Therapy for Rare Muscle Disease

Novartis said its RNA therapy del-brax met goals of a Phase 1/2 study in facioscapulohumeral muscular dystrophy (FSHD), an inherited muscle disorder that currently has no FDA-approved medicines. Del-brax is one of three RNA therapies from Novartis’s $12 billion acquisition of Avidity Biosciences. The post Novartis RNA Med From $12B Deal Keeps Building Case to…

Read More

Medicare Part D Enrollment, Premiums, and Cost Sharing in 2026

The Medicare Part D program provides an outpatient prescription drug benefit to 56 million older adults and people with long-term disabilities in Medicare who enroll in private plans. This brief analyzes Medicare Part D enrollment, premiums, and cost sharing in 2026 and trends over time, based on data from the Centers for Medicare & Medicaid…

Read More